vs
Ingevity Corp（NGVT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Ingevity Corp的1.1倍（$197.9M vs $185.4M），REPLIGEN CORP净利率更高（6.7% vs -45.6%，领先52.3%），Ingevity Corp同比增速更快（36.7% vs 13.6%），Ingevity Corp自由现金流更多（$73.5M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -26.2%）
Ingevity Corp是一家全球特种化学品与先进材料生产商，主营高性能碳材料、路面养护解决方案及特种化工产品，服务汽车排放控制、工业净化、道路基建、农业投入品等核心市场，业务覆盖北美、欧洲及亚太地区。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NGVT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$185.4M
营收增速更快
NGVT
高出23.1%
13.6%
净利率更高
RGEN
高出52.3%
-45.6%
自由现金流更多
NGVT
多$55.9M
$17.6M
两年增速更快
RGEN
近两年复合增速
-26.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.4M | $197.9M |
| 净利润 | $-84.6M | $13.3M |
| 毛利率 | 41.2% | 52.5% |
| 营业利润率 | -47.7% | 9.0% |
| 净利率 | -45.6% | 6.7% |
| 营收同比 | 36.7% | 13.6% |
| 净利润同比 | -609.6% | 143.9% |
| 每股收益（稀释后） | $-2.33 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NGVTRGEN
| Q4 25 | $185.4M | $197.9M | ||
| Q3 25 | $333.1M | $188.8M | ||
| Q2 25 | $365.1M | $182.4M | ||
| Q1 25 | $284.0M | $169.2M | ||
| Q4 24 | $135.6M | $174.1M | ||
| Q3 24 | $333.8M | $154.9M | ||
| Q2 24 | $390.6M | $154.1M | ||
| Q1 24 | $340.1M | $151.3M |
净利润NGVTRGEN
| Q4 25 | $-84.6M | $13.3M | ||
| Q3 25 | $43.5M | $14.9M | ||
| Q2 25 | $-146.5M | $14.9M | ||
| Q1 25 | $20.5M | $5.8M | ||
| Q4 24 | $16.6M | $-30.3M | ||
| Q3 24 | $-107.2M | $-654.0K | ||
| Q2 24 | $-283.7M | $3.3M | ||
| Q1 24 | $-56.0M | $2.1M |
毛利率NGVTRGEN
| Q4 25 | 41.2% | 52.5% | ||
| Q3 25 | 40.2% | 53.2% | ||
| Q2 25 | 37.8% | 50.0% | ||
| Q1 25 | 39.9% | 53.6% | ||
| Q4 24 | 81.3% | 26.1% | ||
| Q3 24 | 39.4% | 50.0% | ||
| Q2 24 | 31.5% | 49.8% | ||
| Q1 24 | 29.3% | 49.5% |
营业利润率NGVTRGEN
| Q4 25 | -47.7% | 9.0% | ||
| Q3 25 | 18.7% | 8.9% | ||
| Q2 25 | -39.1% | 7.6% | ||
| Q1 25 | 9.4% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 33.0% | -5.1% | ||
| Q2 24 | 25.9% | 1.0% | ||
| Q1 24 | 22.6% | 1.3% |
净利率NGVTRGEN
| Q4 25 | -45.6% | 6.7% | ||
| Q3 25 | 13.1% | 7.9% | ||
| Q2 25 | -40.1% | 8.2% | ||
| Q1 25 | 7.2% | 3.4% | ||
| Q4 24 | 12.2% | -17.4% | ||
| Q3 24 | -32.1% | -0.4% | ||
| Q2 24 | -72.6% | 2.2% | ||
| Q1 24 | -16.5% | 1.4% |
每股收益（稀释后）NGVTRGEN
| Q4 25 | $-2.33 | $0.24 | ||
| Q3 25 | $1.18 | $0.26 | ||
| Q2 25 | $-4.02 | $0.26 | ||
| Q1 25 | $0.56 | $0.10 | ||
| Q4 24 | $0.44 | $-0.55 | ||
| Q3 24 | $-2.94 | $-0.01 | ||
| Q2 24 | $-7.81 | $0.06 | ||
| Q1 24 | $-1.54 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.1M | $767.6M |
| 总债务越低越好 | $1.2B | $542.2M |
| 股东权益账面价值 | $29.7M | $2.1B |
| 总资产 | $1.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 39.10× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NGVTRGEN
| Q4 25 | $78.1M | $767.6M | ||
| Q3 25 | $83.4M | $748.7M | ||
| Q2 25 | $76.9M | $708.9M | ||
| Q1 25 | $71.5M | $697.2M | ||
| Q4 24 | $68.0M | $757.4M | ||
| Q3 24 | $135.5M | $784.0M | ||
| Q2 24 | $107.4M | $809.1M | ||
| Q1 24 | $88.5M | $780.6M |
总债务NGVTRGEN
| Q4 25 | $1.2B | $542.2M | ||
| Q3 25 | $1.2B | $537.9M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $525.6M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
股东权益NGVTRGEN
| Q4 25 | $29.7M | $2.1B | ||
| Q3 25 | $138.1M | $2.1B | ||
| Q2 25 | $120.7M | $2.1B | ||
| Q1 25 | $234.6M | $2.0B | ||
| Q4 24 | $195.2M | $2.0B | ||
| Q3 24 | $214.5M | $2.0B | ||
| Q2 24 | $284.8M | $2.0B | ||
| Q1 24 | $568.2M | $2.0B |
总资产NGVTRGEN
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.8B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $2.1B | $2.9B | ||
| Q4 24 | $2.0B | $2.8B | ||
| Q3 24 | $2.2B | $2.8B | ||
| Q2 24 | $2.3B | $2.9B | ||
| Q1 24 | $2.6B | $2.8B |
负债/权益比NGVTRGEN
| Q4 25 | 39.10× | 0.26× | ||
| Q3 25 | 8.39× | 0.26× | ||
| Q2 25 | 10.24× | — | ||
| Q1 25 | 5.68× | — | ||
| Q4 24 | 6.86× | 0.27× | ||
| Q3 24 | 6.52× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 2.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $97.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $73.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 39.6% | 8.9% |
| 资本支出强度资本支出/营收 | 12.7% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $273.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流NGVTRGEN
| Q4 25 | $97.1M | $25.7M | ||
| Q3 25 | $129.7M | $48.1M | ||
| Q2 25 | $79.0M | $28.6M | ||
| Q1 25 | $25.4M | $15.0M | ||
| Q4 24 | $64.5M | $39.2M | ||
| Q3 24 | $46.5M | $49.3M | ||
| Q2 24 | $29.7M | $42.2M | ||
| Q1 24 | $-12.1M | $44.7M |
自由现金流NGVTRGEN
| Q4 25 | $73.5M | $17.6M | ||
| Q3 25 | $117.8M | $43.4M | ||
| Q2 25 | $66.8M | $21.5M | ||
| Q1 25 | $15.4M | $11.4M | ||
| Q4 24 | $39.6M | $33.6M | ||
| Q3 24 | $28.5M | $42.3M | ||
| Q2 24 | $11.6M | $37.4M | ||
| Q1 24 | $-28.7M | $36.4M |
自由现金流率NGVTRGEN
| Q4 25 | 39.6% | 8.9% | ||
| Q3 25 | 35.4% | 23.0% | ||
| Q2 25 | 18.3% | 11.8% | ||
| Q1 25 | 5.4% | 6.8% | ||
| Q4 24 | 29.2% | 19.3% | ||
| Q3 24 | 8.5% | 27.3% | ||
| Q2 24 | 3.0% | 24.3% | ||
| Q1 24 | -8.4% | 24.0% |
资本支出强度NGVTRGEN
| Q4 25 | 12.7% | 4.1% | ||
| Q3 25 | 3.6% | 2.5% | ||
| Q2 25 | 3.3% | 3.9% | ||
| Q1 25 | 3.5% | 2.1% | ||
| Q4 24 | 18.4% | 3.2% | ||
| Q3 24 | 5.4% | 4.5% | ||
| Q2 24 | 4.6% | 3.1% | ||
| Q1 24 | 4.9% | 5.5% |
现金转化率NGVTRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.98× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 1.24× | 2.57× | ||
| Q4 24 | 3.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVT
| Performance Materials | $151.2M | 82% |
| Advanced Polymer Technologies Segment | $36.5M | 20% |
RGEN
暂无分部数据
